Table 1. MLST and antibiotic susceptibility results of 373 S. epidermidis blood culture isolates from patients with hematological malignancies.
| ST | CC | N (%) | MLST profile | MRSE % | MDR % |
| 2 | 2-I | 243 (65) | 7-1-2-2-4-1-1 | 95 | 86 |
| 215 | 2-II | 28 (7.5) | 1-6-2-1-1-16-1 | 93 | 89 |
| 73 | 2-II | 11 (2.9) | 1-5-2-6-2-1-6 | 0 | 0 |
| 23 | 2-II | 9 (2.4) | 7-1-2-1-3-3-1 | 89 | 100 |
| 5 | 2-II | 7 (1.9) | 1-1-1-2-2-1-1 | 57 | 71 |
| 22 | 2-I | 6 (1.6) | 7-1-2-2-4-7-1 | 100 | 67 |
| 38 | 2-II | 6 (1.6) | 1-2-2-5-1-1-10 | 33 | 17 |
| 57 | 2-II | 6 (1.6) | 1-1-1-1-2-1-1 | 0 | 17 |
| 59 | 2-II | 6 (1.6) | 2-1-1-1-2-1-1 | 67 | 67 |
| 6 | 2-II | 3 (0.8) | 1-1-2-2-2-1-1 | 67 | 67 |
| 25 | 2-II | 3 (0.8) | 1-6-2-1-1-1-3 | 100 | 100 |
| 295 | 2-II | 3 (0.8) | 1-1-3-6-2-1-1 | 0 | 0 |
| 17 | 2-II | 2 (0.5) | 1-1-6-2-2-1-1 | 0 | 17 |
| 19 | Undefined | 2 (0.5) | 8-7-12-4-12-2-2 | 0 | 0 |
| 32 | Singleton | 2 (0.5) | 1-1-7-1-3-5-14 | 0 | 0 |
| 173 | 2-II | 2 (0.5) | 1-6-6-1-2-1-10 | 0 | 100 |
| 225 | 2-II | 2 (0.5) | 1-13-7-2-2-1-29 | 0 | 0 |
| 520 | 2-II | 2 (0.5) | 1-1-2-1-1-1-33 | 0 | 0 |
| 524 | 2-II | 2 (0.5) | 1-1-2-2-4-16-1 | 0 | 0 |
| 1 | 2-II | 1 (0.3) | 1-2-2-2-1-1-10 | 100 | 100 |
| 4 | 2-II | 1 (0.3) | 1-1-6-6-2-1-1 | 100 | 100 |
| 7 | 2-II | 1 (0.3) | 1-1-1-2-4-1-1 | 0 | 0 |
| 10 | 2-II | 1 (0.3) | 1-1-1-1-3-1-1 | 100 | 100 |
| 40 | 2-II | 1 (0.3) | 1-1-2-1-3-1-1 | 100 | 100 |
| 53 | 365 | 1 (0.3) | 3-1-5-5-11-4-11 | 0 | 0 |
| 85 | 2-II | 1 (0.3) | 1-1-2-2-1-1-1 | 0 | 0 |
| 86 | 2-II | 1 (0.3) | 1-2-2-1-1-1-1 | 0 | 0 |
| 88 | 2-II | 1 (0.3) | 1-1-2-1-2-1-7 | 0 | 0 |
| 136 | 2-II | 1 (0.3) | 1-1-7-2-2-1-1 | 0 | 0 |
| 152 | 2-II | 1 (0.3) | 1-1-2-6-2-1-1 | 0 | 0 |
| 190 | 2-II | 1 (0.3) | 1-1-1-2-5-1-1 | 0 | 0 |
| 210 | 2-II | 1 (0.3) | 1-1-1-2-2-1-25 | 0 | 0 |
| 218 | 2-II | 1 (0.3) | 1-1-2-6-2-16-1 | 0 | 0 |
| 327 | 2-II | 1 (0.3) | 1-1-2-1-4-1-1 | 0 | 0 |
| 337 | Singleton | 1 (0.3) | 32-10-10-9-10-16-31 | 0 | 0 |
| 372 | 365 | 1 (0.3) | 12-25-5-5-3-4-11 | 0 | 0 |
| 414 | 2-II | 1 (0.3) | 1-1-1-1-2-1-4 | 0 | 0 |
| 457 | Singleton | 1 (0.3) | 3-16-16-5-3-19-31 | 0 | 0 |
| 521 | 2-II | 1 (0.3) | 1-23-3-6-2-1-10 | 0 | 0 |
| 522 | Singleton | 1 (0.3) | 32-1-10-2-10-1-1 | 0 | 0 |
| 523 | 2-II | 1 (0.3) | 1-6-2-5-1-16-1 | 100 | 100 |
| 525 | 2-II | 1 (0.3) | 1-2-1-1-2-1-1 | 0 | 100 |
| 526 | Singleton | 1 (0.3) | 8-24-17-4-12-6-9 | 0 | 0 |
| 527 | 2-II | 1 (0.3) | 43-6-6-1-2-1-10 | 0 | 100 |
| 528 | 2-II | 1 (0.3) | 1-1-7-2-2-1-29 | 0 | 100 |
| Untypeable | - | 2 (0.5) | - | 50 | 0 |
| Total | 373 | 78 | 73 |
ST, sequence type, CC, clonal complex, MLST, multi locus sequence typing, MRSE, methicillin resistant S. epidermidis, MDR, multidrug resistant (≥3 antibiotic groups)